Research Article

Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma

Figure 6

Implication of the cuproptosis-relevant lncRNA signature in immunotherapy. (a) The abundance levels of tumor-infiltrating immune cells calculated by diverse computational approaches in low- and high-risk subsets. (b) Expression patterns of immune checkpoints, cytolytic activity- and IFN-γ response-relevant markers across low- and high-risk subsets. (c) Landscape of mRNA expression, expression vs. methylation (mRNA expression correlated to DNA-methylation β values), amplification, and deletion frequencies for immunomodulators in low- and high-risk subsets.